Cargando…
Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy
Chemotherapy is currently an irreplaceable strategy for cancer treatment. Doxorubicin hydrochloride (DOX) is a clinical first-line drug for cancer chemotherapy. While its efficacy for cancer treatment is greatly compromised due to invalid enrichment or serious side effects. To increase the content o...
Autores principales: | Qiao, Lei, Yuan, Xue, Peng, Hui, Shan, Guisong, Gao, Min, Yi, Xiaoqing, He, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530493/ https://www.ncbi.nlm.nih.gov/pubmed/34668829 http://dx.doi.org/10.1080/10717544.2021.1986602 |
Ejemplares similares
-
Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy
por: Wei, Yuping, et al.
Publicado: (2017) -
Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles
por: Rodzinski, Alexandra, et al.
Publicado: (2016) -
Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
por: Lee, Sang Joon, et al.
Publicado: (2015) -
Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy
por: Heo, Min Beom, et al.
Publicado: (2015) -
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
por: Puris, Elena, et al.
Publicado: (2023)